Global Human Embryonic Stem Cells Market Professional Survey Report 2016
- QYR590926
- 107 Pages
- June 2016
- Pharmaceuticals
Product types including
Adult Sources
Fetal Sources
Others
The segment applications including
Hematopoietic stem cell transplantation
Tissue repair damage
Autoimmune diseases
As gene therapy vectors.
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
TiGenix N.V
PromoCell
Ocata Therapeutics Inc.
Orthofix International N.V.
NuVasive Inc.
Life Technologies Corporation
Lonza Group Ltd.
Genlantis
Kite Pharma Inc.
Cynata Therapeutics Ltd.
Cesca Therapeutics Inc.
CellTherapies P/L
BrainStorm Cell Therapeutics Inc.
BioRestorative Therapies Inc.
Anterogen Co., Ltd
Vericel Corporation
Sumanas
Beike Biotechnology
Aastrom Biosciences
With 19 top producers.
Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Human Embryonic Stem Cells
1.1 Definition and Specifications of Human Embryonic Stem Cells
1.1.1 Definition of Human Embryonic Stem Cells
1.1.2 Specifications of Human Embryonic Stem Cells
1.2 Classification of Human Embryonic Stem Cells
1.2.1 Adult Sources
1.2.2 Fetal Sources
1.2.3 Others
1.3 Applications of Human Embryonic Stem Cells
1.3.1 Hematopoietic stem cell transplantation
1.3.2 Tissue repair damage
1.3.3 Autoimmune diseases
1.3.4 As gene therapy vectors.
1.4 Industry Chain Structure of Human Embryonic Stem Cells
1.5 Industry Overview and Major Regions Status of Human Embryonic Stem Cells
1.5.1 Industry Overview of Human Embryonic Stem Cells
1.5.2 Global Major Regions Status of Human Embryonic Stem Cells
1.6 Industry Policy Analysis of Human Embryonic Stem Cells
1.7 Industry News Analysis of Human Embryonic Stem Cells
2 Manufacturing Cost Structure Analysis of Human Embryonic Stem Cells
2.1 Raw Material Suppliers and Price Analysis of Human Embryonic Stem Cells
2.2 Equipment Suppliers and Price Analysis of Human Embryonic Stem Cells
2.3 Labor Cost Analysis of Human Embryonic Stem Cells
2.4 Other Costs Analysis of Human Embryonic Stem Cells
2.5 Manufacturing Cost Structure Analysis of Human Embryonic Stem Cells
2.6 Manufacturing Process Analysis of Human Embryonic Stem Cells
3 Technical Data and Manufacturing Plants Analysis of Human Embryonic Stem Cells
3.1 Capacity and Commercial Production Date of Global Human Embryonic Stem Cells Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Human Embryonic Stem Cells Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Human Embryonic Stem Cells Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Human Embryonic Stem Cells Major Manufacturers in 2015
4 Global Human Embryonic Stem Cells Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Human Embryonic Stem Cells Capacity and Growth Rate Analysis
4.2.2 2015 Human Embryonic Stem Cells Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Human Embryonic Stem Cells Sales and Growth Rate Analysis
4.3.2 2015 Human Embryonic Stem Cells Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Human Embryonic Stem Cells Sales Price
4.4.2 2015 Human Embryonic Stem Cells Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Human Embryonic Stem Cells Gross Margin
4.5.2 2015 Human Embryonic Stem Cells Gross Margin Analysis (Company Segment)
5 Human Embryonic Stem Cells Regional Market Analysis
5.1 North America Human Embryonic Stem Cells Market Analysis
5.1.1 North America Human Embryonic Stem Cells Market Overview
5.1.2 North America 2011-2016E Human Embryonic Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Human Embryonic Stem Cells Sales Price Analysis
5.1.4 North America 2015 Human Embryonic Stem Cells Market Share Analysis
5.2 Europe Human Embryonic Stem Cells Market Analysis
5.2.1 Europe Human Embryonic Stem Cells Market Overview
5.2.2 Europe 2011-2016E Human Embryonic Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Human Embryonic Stem Cells Sales Price Analysis
5.2.4 Europe 2015 Human Embryonic Stem Cells Market Share Analysis
5.3 Japan Human Embryonic Stem Cells Market Analysis
5.3.1 Japan Human Embryonic Stem Cells Market Overview
5.3.2 Japan 2011-2016E Human Embryonic Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Human Embryonic Stem Cells Sales Price Analysis
5.3.4 Japan 2015 Human Embryonic Stem Cells Market Share Analysis
5.4 China Human Embryonic Stem Cells Market Analysis
5.4.1 China Human Embryonic Stem Cells Market Overview
5.4.2 China 2011-2016E Human Embryonic Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Human Embryonic Stem Cells Sales Price Analysis
5.4.4 China 2015 Human Embryonic Stem Cells Market Share Analysis
5.5 Southeast Asia Human Embryonic Stem Cells Market Analysis
5.5.1 Southeast Asia Human Embryonic Stem Cells Market Overview
5.5.2 Southeast Asia 2011-2016E Human Embryonic Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Human Embryonic Stem Cells Sales Price Analysis
5.5.4 Southeast Asia 2015 Human Embryonic Stem Cells Market Share Analysis
5.6 India Human Embryonic Stem Cells Market Analysis
5.6.1 India Human Embryonic Stem Cells Market Overview
5.6.2 India 2011-2016E Human Embryonic Stem Cells Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Human Embryonic Stem Cells Sales Price Analysis
5.6.4 India 2015 Human Embryonic Stem Cells Market Share Analysis
6 Global 2011-2016E Human Embryonic Stem Cells Segment Market Analysis (by Type)
6.1 Global 2011-2016E Human Embryonic Stem Cells Sales by Type
6.2 Different Types Human Embryonic Stem Cells Product Interview Price Analysis
6.3 Different Types Human Embryonic Stem Cells Product Driving Factors Analysis
6.3.1 Adult Sources Human Embryonic Stem Cells Growth Driving Factor Analysis
6.3.2 Fetal Sources Human Embryonic Stem Cells Growth Driving Factor Analysis
6.3.3 Others Human Embryonic Stem Cells Growth Driving Factor Analysis
7 Global 2011-2016E Human Embryonic Stem Cells Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hematopoietic stem cell transplantation Human Embryonic Stem Cells Growth Driving Factor Analysis
7.3.2 Tissue repair damage Human Embryonic Stem Cells Growth Driving Factor Analysis
7.3.3 Autoimmune diseases Human Embryonic Stem Cells Growth Driving Factor Analysis
7.3.4 As gene therapy vectors. Human Embryonic Stem Cells Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Human Embryonic Stem Cells
8.1 TiGenix N.V
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 TiGenix N.V 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 TiGenix N.V 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.2 PromoCell
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 PromoCell 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 PromoCell 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.3 Ocata Therapeutics Inc.
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Ocata Therapeutics Inc. 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Ocata Therapeutics Inc. 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.4 Orthofix International N.V.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Orthofix International N.V. 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Orthofix International N.V. 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.5 NuVasive Inc.
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 NuVasive Inc. 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 NuVasive Inc. 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.6 Life Technologies Corporation
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Life Technologies Corporation 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Life Technologies Corporation 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.7 Lonza Group Ltd.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Lonza Group Ltd. 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Lonza Group Ltd. 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.8 Genlantis
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Genlantis 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Genlantis 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.9 Kite Pharma Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Kite Pharma Inc. 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Kite Pharma Inc. 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.10 Cynata Therapeutics Ltd.
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Cynata Therapeutics Ltd. 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Cynata Therapeutics Ltd. 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.11 Cesca Therapeutics Inc.
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Cesca Therapeutics Inc. 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Cesca Therapeutics Inc. 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.12 CellTherapies P/L
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 CellTherapies P/L 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 CellTherapies P/L 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.13 BrainStorm Cell Therapeutics Inc.
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 BrainStorm Cell Therapeutics Inc. 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 BrainStorm Cell Therapeutics Inc. 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.14 BioRestorative Therapies Inc.
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 BioRestorative Therapies Inc. 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 BioRestorative Therapies Inc. 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.15 Anterogen Co., Ltd
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Anterogen Co., Ltd 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Anterogen Co., Ltd 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.16 Vericel Corporation
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Vericel Corporation 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Vericel Corporation 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.17 Sumanas
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Sumanas 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Sumanas 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.18 Beike Biotechnology
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Beike Biotechnology 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Beike Biotechnology 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
8.19 Aastrom Biosciences
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Aastrom Biosciences 2015 Human Embryonic Stem Cells Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Aastrom Biosciences 2015 Human Embryonic Stem Cells Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Human Embryonic Stem Cells Consumption Forecast
9.2.2 Europe 2016-2021 Human Embryonic Stem Cells Consumption Forecast
9.2.3 Japan 2016-2021 Human Embryonic Stem Cells Consumption Forecast
9.2.4 China 2016-2021 Human Embryonic Stem Cells Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Human Embryonic Stem Cells Consumption Forecast
9.2.6 India 2016-2021 Human Embryonic Stem Cells Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Human Embryonic Stem Cells Marketing Model Analysis
10.1 Human Embryonic Stem Cells Regional Marketing Model Analysis
10.2 Human Embryonic Stem Cells International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Human Embryonic Stem Cells by Regions
10.4 Human Embryonic Stem Cells Supply Chain Analysis
11 Consumers Analysis of Human Embryonic Stem Cells
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Human Embryonic Stem Cells
12.1 New Project SWOT Analysis of Human Embryonic Stem Cells
12.2 New Project Investment Feasibility Analysis of Human Embryonic Stem Cells
13 Conclusion of the Global Human Embryonic Stem Cells Market Professional Survey Report 2016
N/A
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
